BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34109413)

  • 1. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
    Ott C; Mahfoud F; Mancia G; Narkiewicz K; Ruilope LM; Fahy M; Schlaich MP; Böhm M; Schmieder RE
    Nephrol Dial Transplant; 2022 Jan; 37(2):304-310. PubMed ID: 34109413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
    Mahfoud F; Böhm M; Schmieder R; Narkiewicz K; Ewen S; Ruilope L; Schlaich M; Williams B; Fahy M; Mancia G
    Eur Heart J; 2019 Nov; 40(42):3474-3482. PubMed ID: 30907413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.
    Günes-Altan M; Schmid A; Ott C; Bosch A; Pietschner R; Schiffer M; Uder M; Schmieder RE; Kannenkeril D
    Clin Kidney J; 2024 Jan; 17(1):sfad237. PubMed ID: 38186882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal denervation on kidney function in patients with chronic kidney disease.
    Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
    Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L; Li C; Li Z; Li Q; Liu C; Sun X; He Q; Xia DS; Xia D; Lu C
    J Hypertens; 2024 May; 42(5):801-808. PubMed ID: 38164953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
    Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
    Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE.
    Mahfoud F; Mancia G; Schmieder RE; Ruilope L; Narkiewicz K; Schlaich M; Williams B; Ribichini F; Weil J; Almerri K; Sharif F; Lauder L; Wanten M; Fahy M; Böhm M
    Hypertension; 2023 Aug; 80(8):1759-1770. PubMed ID: 37317866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
    J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.
    Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M
    Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
    Singh RR; McArdle ZM; Iudica M; Easton LK; Booth LC; May CN; Parkington HC; Lombardo P; Head GA; Lambert G; Moritz KM; Schlaich MP; Denton KM
    Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
    Vogel B; Kirchberger M; Zeier M; Stoll F; Meder B; Saure D; Andrassy M; Mueller OJ; Hardt S; Schwenger V; Strothmeyer A; Katus HA; Blessing E
    Clin Res Cardiol; 2014 Feb; 103(2):117-24. PubMed ID: 24126436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
    Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
    EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.